Skip to main content

ORIGINAL RESEARCH article

Front. Endocrinol.
Sec. Cancer Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1546530
This article is part of the Research Topic Cancer Biology, Immunotherapy and Aging View all 6 articles

Identification of the high-risk population facing early death in older patients with primary intracranial glioma: a retrospective cohort study

Provisionally accepted
Gui-Jun Lu Gui-Jun Lu Ying Zhao Ying Zhao Rui Huang Rui Huang *
  • Second Affiliated Hospital of Jilin University, Changchun, China

The final, formatted version of the article will be published soon.

    Background: This study aimed to establish a diagnostic nomogram to predict the early death risk in older patients with primary intracranial glioma and to identify the highrisk population in those patients to provide them with specialized care to increase their benefit from survival.Methods: Patients aged 60 years and older with histologically confirmed intracranial glioma were identified in the Surveillance, Epidemiology and End Results (SEER) database. Initially, they were divided into a training set and a validation set in a 7:3 ratio. Next, univariate and multivariate logistic regression were employed to identify independent risk variables, which were used to develop a diagnostic nomogram further.Additional analyses were performed on the diagnostic nomogram's performance, including calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). A mortality risk classification system was ultimately developed using the diagnostic nomogram.Results: This study included 8,859 individuals diagnosed with primary intracranial glioma. The participants were randomly split into two groups: a training set consisting of 6203 individuals and a validation set consisting of 2,656 individuals, with a ratio of 7 to 3. Univariate and multivariate logistic regression analyses on early death showed 7 independent risk variables (age, median household income, histological type, surgery, radiation therapy, and systemic therapy sequence with surgery) in the training set. A diagnostic nomogram for predicting the early death risk was created based on these variables. Calibration curves showed a high agreement between the expected and actual probabilities. The AUC for the training and validation sets were 0.798 and 0.811, respectively. Meanwhile, the novel-created diagnostic nomogram had the highest AUC value compared to each independent risk variables, which showed that the nomogram had the best discriminatory ability. The DCA indicated that the nomogram has the potential to provide greater clinical advantages across a broad spectrum of threshold probabilities. This study created a novel diagnostic nomogram to predict the probability of early death in older patients with intracranial glioma. In the meantime, a nomogram-based risk classification system was also constructed to help us identify the high-risk population facing early death and provide them with specialized care to increase their benefit from survival.

    Keywords: early death, high-risk, older, Intracranial glioma, nomogram, SEER

    Received: 17 Dec 2024; Accepted: 06 Feb 2025.

    Copyright: © 2025 Lu, Zhao and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Rui Huang, Second Affiliated Hospital of Jilin University, Changchun, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.